CLINICAL_TRIALS
trial_result
· 2009-09-23
Clinical Trial Update: V260 Registration Study (V260-013)(COMPLETED) [Phase 3]
Summary
Phase 3 registration study V260-013 for rotavirus completed; results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2009-09-23